A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback